Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00525304 · ClinicalTrials.gov registry record · NA

A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition

A NA study of Schizophrenia, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT00525304 is a NA study of Schizophrenia that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 100 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00525304, a NA study of Schizophrenia, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study will develop and evaluate the effectiveness of a self-management program for adults living with both schizophrenia and a co-occurring medical condition.

Conditions Studied

Interventions

  • BEHAVIORAL Self-management program for chronic illness

Study Locations (1)

Maryland

  • Fayette Street Clinics - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2007-09
Est. Completion 2015-05
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT00525304

The ClinicalTrials.gov registry entry for NCT00525304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (54% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Self-management program for chronic illness is the first listed.

NCT00525304 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00525304 about?

NCT00525304 is a clinical study titled "A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition". This study will develop and evaluate the effectiveness of a self-management program for adults living with both schizophrenia and a co-occurring medical condition.

What is the current status of trial NCT00525304?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2007-09. Estimated completion is 2015-05.

What conditions does trial NCT00525304 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT00525304?

The interventions under investigation include: Self-management program for chronic illness (BEHAVIORAL).

Who is sponsoring clinical trial NCT00525304?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00525304 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.